212 Direct Evidence of Chronic Epithelial Injury and Dysregulated Repair in the Lung Allograft
Journal of Heart and Lung Transplantation, Apr 1, 2012
the presentation of EMT with the onset of BOS and triggering clinical events such as acute reject... more the presentation of EMT with the onset of BOS and triggering clinical events such as acute rejection, infections, or GERD, highlighting the potential for inhibition of EMT as a therapeutic target. Methods and Materials: We analyzed over 300 post-transplant transbronchial biopsy specimens from patients at several time points between 3-60 months. Using confocal immunofluorescence imaging, we looked for the onset of co-staining of epithelial and mesenchymal markers such as Ecadherin and Vimentin, or ZO-1 and alpha-SMA in conjunction with clinical data from the same subject. We then assayed bronchial-alveolar lavage (BAL) fluid from the same subset of patients for the presence of pro-EMT cytokines including TGF, TNF, and IL-17. Finally, we cultured primary small airway cells with TGF, TNF, and N-acetylcysteine and assessed the inhibition of EMT markers by immunoblot. Results: We found significantly increased expression of EMT markers in correlation with progressed stage of BOS compared to that of samples taken at stable time points, with the presentation of EMT typically preceding clinically assessed decline in lung function. Pro-EMT cytokines were present in BAL fluid at time points prior to a significant drop in FEV1, which are to be correlated with aggravating clinical episodes. NAC inhibition of EMT resulted in the suppression of mesenchymal Vimentin and Fibronectin but failed to preserve epithelial E-cadherin expression. Conclusions: EMT seems to play a role in the development of BOS, presenting prior to declination of lung function. Myofibroblasts derived via EMT may be the primary source of excess scar tissue occluding the small airways as seen in BOS. Production of pro-EMT cytokines may be aggravated by acute rejection and infection and may further instigate EMT and the progression of BOS. Therapies aimed at inhibiting EMT have the potential to slow the progression of BOS and prolong the life of the transplanted lung.
Uploads
Papers by Anthony Kicic